In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Latest From Nevro Corp.

NANS 2020: Boston Scientific Expects Neuromodulation Business Rebound In 2020

At NANS, Boston Scientific presented results of the COMBO study, announced a partnership with IBM Research on digital health, and reported strong US growth in its deep brain stimulation business. Boston's C suite sees rebound for lagging neuromodulation business in 2020.

Neurology Clinical Trials

NANS 2020: Medtronic’s DTM Spinal Cord Stimulation Relieves Back Pain In Trial

Three-month results from a 94-patient randomized trial of Medtronic’s Intellis spinal cord stimulation system showed superior back-pain relief with the differential target multiplexed waveform compared to conventional spinal cord stimulation.

Clinical Trials Research & Development

Abbott Wins FDA Approval For 'Low Dose' Non-Rechargeable Spinal Cord Stimulator

Abbott won US FDA approval for its Proclaim XR spinal cord stimulator. The device offers lower-dose and recharge-free neurostimulation for patients with chronic pain with a battery life for up to 10 years.

Neurology Approvals

Nevro Files Patent Suit Against Stimwave

Chronic pain treatment company Nevro has filed suit against rival Stimwave Tech alleging patent infringement.

Legal Issues Intellectual Property
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Other Names / Subsidiaries
    • Nevro Medical Limited
    • Nevro Medical Pty Ltd.
    • Nevro Medical Sarl
UsernamePublicRestriction

Register